These findings further suggest that Nox2 NADPH oxidase-derived ROS mediate the decreases in myocardial sympathetic nerve terminal density, norepinephrine synthesis and norepinephrine uptake in doxorubicin-induced heart failure. The gene discussed is FMO5; the disease is heart failure.